title: Summaries for patients. Sirolimus therapy in patients with lymphangioleiomyomatosis.
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D049109:Cell Proliferation / Q000187:drug effects; D002913:Chyle / Q000378:metabolism; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D008168:Lung / Q000000981:diagnostic imaging / Q000503:physiopathology*; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D018192:Lymphangioleiomyomatosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D008875:Middle Aged; D009130:Muscle, Smooth / Q000473:pathology; D010996:Pleural Effusion / Q000000981:diagnostic imaging / Q000503:physiopathology*; D011859:Radiography; D020123:Sirolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
chemical_list: D000903:Antibiotics, Antineoplastic; D007166:Immunosuppressive Agents; D020123:Sirolimus